200 related articles for article (PubMed ID: 30352219)
1. CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.
Mao L; Le S; Jin X; Liu G; Chen J; Hu J
Exp Cell Res; 2019 Jan; 374(2):274-281. PubMed ID: 30352219
[TBL] [Abstract][Full Text] [Related]
2. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
[TBL] [Abstract][Full Text] [Related]
3. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
[TBL] [Abstract][Full Text] [Related]
4. CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis.
Wan Z; Huang S; Mo F; Yao Y; Liu G; Han Z; Chen M; Zhiyun L
Exp Cell Res; 2019 Nov; 384(2):111646. PubMed ID: 31560888
[TBL] [Abstract][Full Text] [Related]
5. PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1.
Ma Y; Xia P; Wang Z; Xu J; Zhang L; Jiang Y
Neoplasia; 2021 Sep; 23(9):912-928. PubMed ID: 34325342
[TBL] [Abstract][Full Text] [Related]
6. FoxM1 affects adhesive, migratory, and invasive abilities of human retinoblastoma Y-79 cells by targeting matrix metalloproteinase 2.
Zhu X; Yu M; Wang K; Zou W; Zhu L
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):294-301. PubMed ID: 32152631
[TBL] [Abstract][Full Text] [Related]
7. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
[TBL] [Abstract][Full Text] [Related]
8. CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivin.
Li J; Li Y; Wang B; Ma Y; Chen P
Biochem Biophys Res Commun; 2018 Jun; 500(2):132-138. PubMed ID: 29596838
[TBL] [Abstract][Full Text] [Related]
9. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
Huang M; Xiong H; Luo D; Xu B; Liu H
Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
[TBL] [Abstract][Full Text] [Related]
10. CSN5 promotes renal cell carcinoma metastasis and EMT by inhibiting ZEB1 degradation.
Zhang S; Hong Z; Chai Y; Liu Z; Du Y; Li Q; Liu Q
Biochem Biophys Res Commun; 2017 Jun; 488(1):101-108. PubMed ID: 28479251
[TBL] [Abstract][Full Text] [Related]
11. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
Zhong G; Li H; Shan T; Zhang N
Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
[TBL] [Abstract][Full Text] [Related]
12. SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis.
Li Z; Li H; Chen J; Luo H; Zeng J; Yao Y; Duan M
Int J Biochem Cell Biol; 2020 Sep; 126():105797. PubMed ID: 32668328
[TBL] [Abstract][Full Text] [Related]
13. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation.
Huang D; Du X; Yuan R; Chen L; Liu T; Wen C; Huang M; Li M; Hao L; Shao J
Biochem Biophys Res Commun; 2014 Oct; 453(1):49-56. PubMed ID: 25251472
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
[TBL] [Abstract][Full Text] [Related]
15. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
[TBL] [Abstract][Full Text] [Related]
16. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ.
Zhang X; Shi G; Gao F; Liu P; Wang H; Tan X
Oncol Rep; 2019 Apr; 41(4):2117-2125. PubMed ID: 30720116
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells.
Wang Z; Banerjee S; Kong D; Li Y; Sarkar FH
Cancer Res; 2007 Sep; 67(17):8293-300. PubMed ID: 17804744
[TBL] [Abstract][Full Text] [Related]
18. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
[TBL] [Abstract][Full Text] [Related]
19. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
[TBL] [Abstract][Full Text] [Related]
20. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
